Cargando…
Safety and efficacy of intravitreal anti vascular endothelial growth factor for severe posterior retinopathy of prematurity with flat fibrovascular proliferation
BACKGROUND: Intravitreal anti-vascular endothelial growth factor (IVA) injection is known to cause contraction of fibrovascular proliferation (FVP), when present in severe retinopathy of prematurity (ROP). AIM: To assess the structural outcomes of IVA injection in the treatment of severe posterior R...
Autores principales: | Maitra, Puja, Prema, Subramaniam, Narendran, Venkatapathy, Shah, Parag K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518743/ https://www.ncbi.nlm.nih.gov/pubmed/37753496 http://dx.doi.org/10.5409/wjcp.v12.i4.220 |
Ejemplares similares
-
Outcomes of transconjuctival sutureless 27-gauge vitrectomy for stage 4 retinopathy of prematurity
por: Shah, Parag K, et al.
Publicado: (2018) -
Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity
por: Shah, Parag K, et al.
Publicado: (2011) -
Clinical profile and outcomes of pediatric endogenous endophthalmitis: A report of 11 cases from South India
por: Murugan, Gayatri, et al.
Publicado: (2016) -
Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
por: Li, Xiu-Juan, et al.
Publicado: (2016) -
Retro-mode imaging of fibrovascular membrane in proliferative diabetic retinopathy after intravitreal bevacizumab injection
por: Suzuma, Kiyoshi, et al.
Publicado: (2011)